Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Makers of the Alleged faulty Hip Implant objected to disclosure on import clearance, overruled by CIC

      Makers of the Alleged faulty Hip Implant objected to disclosure on import clearance, overruled by CIC

      Ruby Khatun Khatun30 Aug 2018 5:45 PM IST
      New Delhi: Importer of alleged faulty hip replacement systems had objected to disclosure of its compliance documents submitted to the Central Drugs...
      Hetero Labs recalls over 15.90 lakh bottles of hypertension drug from US

      Hetero Labs recalls over 15.90 lakh bottles of hypertension drug from US

      Ruby Khatun Khatun30 Aug 2018 11:26 AM IST
      New Delhi: Drug firm Hetero Labs is recalling over 15.90 lakh bottles of Valsartan Tablets used for the treatment of hypertension from the American...
      Laurus Labs gets USFDA approval for diabetes drug

      Laurus Labs gets USFDA approval for diabetes drug

      Ruby Khatun Khatun30 Aug 2018 10:30 AM IST
      New Delhi: Drug firm Laurus Labs said it has received approval from the US health regulator for its Metformin hydrochloride tablets used for the...
      Panacea Biotec inks pact with Natco, Breckenridge for cancer drug

      Panacea Biotec inks pact with Natco, Breckenridge for cancer drug

      Ruby Khatun Khatun30 Aug 2018 10:00 AM IST
      New Delhi: Panacea Biotec said it has inked a tripartite pact with Natco Pharma and Breckenridge Pharmaceutical Inc to manufacture and supply of...
      FDA proposes restricting compounding of three drug substances

      FDA proposes restricting compounding of three drug substances

      Ruby Khatun Khatun30 Aug 2018 9:45 AM IST
      The U.S. Food and Drug Administration (FDA) proposed excluding three substances from a list of ingredients that could be used to manufacture...
      UK rejects Gileads CAR-T cancer cell therapy as too expensive

      UK rejects Gilead's CAR-T cancer cell therapy as too expensive

      Ruby Khatun Khatun30 Aug 2018 9:30 AM IST
      LONDON: A cutting-edge CAR-T cell therapy for otherwise untreatable forms of blood cancer is too expensive to justify its use on Britain’s...
      Why no Criminal action against Johnson and Johnson for faulty hip implants: Patients ask Nadda

      Why no Criminal action against Johnson and Johnson for faulty hip implants: Patients ask Nadda

      Ruby Khatun Khatun29 Aug 2018 3:35 PM IST
      New Delhi: A group of patients, who suffered due to alleged faulty hip replacement surgeries by a multinational firm, said that the Centre's response...
      Lupin gets USFDA approval to market its postherpetic neuralgia drug

      Lupin gets USFDA approval to market its postherpetic neuralgia drug

      Ruby Khatun Khatun29 Aug 2018 1:43 PM IST
      Lupin has received final approval to market its Gabapentin tablets USP in the strengths of 600 mg and 800 mg from USFDA for postherpetic neuralgiaNew...
      Health ministry calls for halting sales of e-cigarettes, smoking devices

      Health ministry calls for halting sales of e-cigarettes, smoking devices

      Ruby Khatun Khatun29 Aug 2018 10:15 AM IST
      New Delhi: Health Ministry called for stopping the sale or import of electronic cigarettes and heat-not-burn tobacco devices that companies like...
      India, EU join hands to develop new Influenza vaccine

      India, EU join hands to develop new Influenza vaccine

      Ruby Khatun Khatun29 Aug 2018 10:15 AM IST
      New Delhi: The Indian government and the European Union (EU), joined hands for Rs. 240 crore research programme to develop a Next Generation Influenza...
      Health info app myUpchar raises over Rs 35 crore in Series A funding

      Health info app myUpchar raises over Rs 35 crore in Series A funding

      Ruby Khatun Khatun29 Aug 2018 10:00 AM IST
      New Delhi: myUpchar, a leader in providing health information in Indian languages, has announced raising funds worth USD 5 million (over Rs 35 crore)...
      USFDA approves Tetraphase Pharmas antibiotic

      USFDA approves Tetraphase Pharma's antibiotic

      Ruby Khatun Khatun29 Aug 2018 9:45 AM IST
      The U. S. Food and Drug Administration approved Tetraphase Pharmaceuticals Inc's antibiotic for complicated intra-abdominal infections, providing a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok